Send mail to Author

Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial) (Article)

Please indicate your contact information and select, which author you want to contact.



 
__    __     ___                 ___       _____    ______  
\ \\ / //   / _ \\    ____      / _ \\    / ___//  /_   _// 
 \ \/ //   / //\ \\  |    \\   / //\ \\   \___ \\   -| ||-  
  \  //   |  ___  || | [] ||  |  ___  ||  /    //   _| ||_  
   \//    |_||  |_|| |  __//  |_||  |_|| /____//   /_____// 
    `     `-`   `-`  |_|`-`   `-`   `-` `-----`    `-----`  
                     `-`                                    
 


Back to frontdoor view